Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter March 1, 2018

Paraprotein interference in the diagnosis of hepatitis C infection

  • Lizhen Ong , Muhammad Bilal Abid , Alexander Yip , Clarice Choong , Wee Joo Chng and Sanjay de Mel EMAIL logo

Corresponding author: Dr. Sanjay de Mel, Department of Haematology-Oncology, National University Cancer Institute, National University Health System, 1E Kent Ridge Road NUHS Tower Block Level 7, Singapore 119228, Singapore

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. European Association for the Study of the Liver. Electronic address eee. EASL Recommendations on treatment of hepatitis C 2016. J Hepatol 2017;66:153–94.10.1016/j.jhep.2016.09.001Search in Google Scholar PubMed

2. Colin C, Lanoir D, Touzet S, Meyaud-Kraemer L, Bailly F, Trepo C, et al. Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature. J Viral Hepat 2001;8:87–95.10.1046/j.1365-2893.2001.00280.xSearch in Google Scholar PubMed

3. Schiettecatte J, Anckaert E, Smitz J. Interferences in immunoassays. In: Chiu NH, editor. Advances in immunoassay technology. InTech, 2012. DOI: 10.5772/35797.10.5772/35797Search in Google Scholar

4. Pantanowitz L, Horowitz GL, Upalakalin JN, Beckwith BA. Artifactual hyperbilirubinemia due to paraprotein interference. Arch Pathol Lab Med 2003;127:55–9.10.5858/2003-127-55-AHDTPSearch in Google Scholar PubMed

5. Lyon AW, Baskin AB. Pseudohyponatremia in a myeloma patient:direct electrode potentiometry is a method worth its salt. Lab Med 2003;34:357–60.10.1309/1LND9XBND712PP0QSearch in Google Scholar

6. Dimeski G, Carter A. Rare IgM interference with Roche/Hitachi Modular glucose and gamma-glutamyltransferase methods in heparin samples. Clin Chem 2005;51:2202–4.10.1373/clinchem.2005.053561Search in Google Scholar PubMed

7. Ostrov BE, Amsterdam D. The interference of monoclonal antibodies with laboratory diagnosis: clinical and diagnostic implications. Immunol Invest 2013;42:673–90.10.3109/08820139.2013.837918Search in Google Scholar PubMed

8. García-González E, Aramendía M, Álvarez-Ballano D, Trincado P, Rello L. Serum sample containing endogenous antibodies interfering with multiple hormone immunoassays. Laboratory strategies to detect interference. Pract Lab Med 2016;4:1–10.10.1016/j.plabm.2015.11.001Search in Google Scholar PubMed PubMed Central

9. Sturgeon CM, Viljoen A. Analytical error and interference in immunoassay: minimizing risk. Ann Clin Biochem 2011;48(Pt 5):418–32.10.1258/acb.2011.011073Search in Google Scholar PubMed

10. Hwang JP, Suarez-Almazor ME, Torres HA, Palla SL, Huang DS, Fisch MJ, et al. Hepatitis C virus screening in patients with cancer receiving chemotherapy. J Oncol Pract 2014;10: e167–74.10.1200/JOP.2013.001215Search in Google Scholar PubMed PubMed Central

Received: 2017-12-08
Accepted: 2018-01-28
Published Online: 2018-03-01
Published in Print: 2018-07-26

©2018 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 29.5.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2017-1148/html
Scroll to top button